It is still a taboo for many men: inability to get an erection intense and long-lasting enough to maintain a complete and satisfactory sexual relationship. In Spain, it is estimated that approximately 19% of men between 25 and 70 years old (between 1.5 and 2 million men) have some degree of erectile dysfunction. A prevalence that increases significantly with age until reaching 50% among those over 70 years of age.
It is not just a sexual problem, in more than half of the cases it presents as a side effect of other pathologies main diseases such as diabetes, vascular, neurological or urological problems. In other cases, the roots of the issue are found in the mind: fear of failure, feelings of guilt, insecurity…
There is already pharmacological treatment for this condition, such as the well-known Viagra, but it does not work in all patients. For these cases, the Department of Urology at the Clínica Universidad de Navarra has launched a trial that seeks to reverse erectile dysfunction with an injection of Onabotulinumtoxin A (botox) in the corpora cavernosa of the penis. The objective, according to Dr. José Enrique Robles, a specialist in Urology, is to find “an effective, safe and long-lasting treatment. “We trust that its effectiveness can be maintained, at least, for six months after the injection.”
The clinical trial, which will have more than 100 patients refractory to conventional treatmentswill include a control group to which a placebo will be administered. The procedure is outpatient, without side effects and practically painless.
The main advantage of this new treatment under study compared to the already known ones is that it avoids taking medication every day or prior to sexual activity. Botox is known for its safety and effectiveness, since it has been applied in various fields of medicine. «Botox relaxes the smooth muscle tissues of the penis. increasing blood flow and thereby providing the appropriate conditions to achieve and maintain an erection,” says Dr. Vanessa Talavera, resident physician at the Department of Urology.
This clinical trial is of an academic nature – not linked to the industry – and has been promoted by the Clínica Universidad de Navarra itself, which considers its objectives to be of general interest to society. “Erectile dysfunction is an alteration whose risk factors are fundamentally vascular and characterized by marked difficulty in achieving and maintaining an erection during sexual activity,” explains Dr. Fernando Ramón de Fata.
People interested in participating in the trial can contact the Department of Urology of the Clínica Universidad de Navarra via email ([email protected]).
#Viagra #doesnt #work #study #Botox #erectile #dysfunction
